ObJectIVe: Renal artery stenosis (RAS) is emerging one of the cause of chronic renal failure and end-stage renal disease. The vast majority of cases in elderly are due to atherosclerotic disease. The prevalence of RAS in several population studies varies considerably. The study aimed to examine the frequency and risk factors of atherosclerotic critical RAS in patients with coronary artery disease.
INtrODuctION
Renal artery stenosis (RAS) is one of the leading causes of chronic kidney disease and is often unrecognized (1, 2) . The vast majority of cases in elderly are due to atherosclerotic disease usually in the presence of widespread disease affecting the coronary vessels, cerebral vasculature, and/or the vessels supplying the lower limbs (3, 4) . RAS is generally associated with changes in left ventricular mass and function and increased risk of cardiovascular disease (5, 6) .
Clinical diagnosis of RAS is often difficult. Clinical manifestations of RAS (resistant hypertension, renal failure, acute decompensated heart failure) are often attributed to other causes. The clinical diagnosis of atherosclerotic RAS remains problematic. This makes it difficult to make the diagnosis and determine the exact prevalence of RAS (7) .
Reported RAS prevalence varies greatly because of different study populations and selection criteria (hypertension, ischemic heart disease, peripheral artery disease (PAD), chronic kidney disease) (8) . The recent guidelines recommend screening the renal arteries at the same time as coronary angiography, especially in patients with a risk of atherosclerotic RAS (9, 10).
The study aimed to examine the prevalence and predictors of atherosclerotic significant RAS (≥50%) in patients with coronary artery disease.
MetHODS
Between May 2007 and December 2012, a total of 762 patients referred to the coronary angiography laboratory with suspected ischemic heart disease underwent coronary and renal angiography at the same session. Patients with accessory renal arteries, acute coronary syndrome, end-stage renal failure and inadequate image quality were excluded from the study. Significant coronary stenosis was defined as ≥50% stenosis for the left main coronary artery and ≥70% stenosis for the other coronary arteries (11) . Selective renal and coronary angiography was performed and evaluated by two independent cardiologists. For measurement, the outer diameter of the catheter was taken as reference and then the decrease in luminal diameter of the imaged renal artery was expressed as the percentage. Significant RAS was defined as ≥50% narrowing in one or both of the main renal arteries. The Ethics Committee approved the study protocol and informed consent was obtained from each patient.
Demographic and clinical characteristics of the patients were recorded. The glomerular filtration rate (GFR) was calculated with the Modification of Diet in Renal Disease (MDRD) formula (12) .
StAtIStIcAL ANALySIS
All statistical analyses were performed using SPSS v. 18.0 for Windows (SPSS, Inc., Chicago, IL, USA). Demographic and clinical characteristics were given as mean ± SD and percentage. The normal distribution of the data was evaluated and then categorical variables were compared using the chi-square test.
The Mann-Whitney U test was used to evaluate non-parametric variables. Multivariate logistic regression analysis was used to determine the independent predictors of RAS. A p-value <0.05 was considered statistically significant.
reSuLtS
The study included 762 consecutive patients (456 males and 306 females). All patients underwent coronary and renal angiography at the same time (Table I ). The mean age of the studied patients was 62 years. The most frequent accompanying chronic disease was hypertension (55.6 %). Dyslipidemia was present in 53.3% and diabetes mellitus in 30.8% of patients while 23.4% patients were smokers. Mean serum creatinine was 0.79 mg/dL and eGFR (MDRD) was 97 ml/min/1.73 m 2 . A total of 355 (46%) patients had at least one coronary vessel involved (one vessel in 127 cases; two vessels in 92; three vessels in 120; LMCA in 16 patients). The renal angiography demonstrated significant RAS (50%) in 68 patients (8.9%), as well as severe stenosis (80%) in 5 patients. The level of RAS was often ostial (89%). There was often single renal artery involvement (unilateral in 87% and bilateral in 13%). Total occlusion of the renal artery was rare (n = 3). There was no complication during renal angiography. Transient contrast-induced nephropathy was observed in 10% of the patients Patients with significant RAS were older, had a history of hypertension more commonly and received more antihypertensive drugs. Systolic blood pressure was higher in patients who had significant RAS (p= 0.001), but the diastolic blood pressure was lower (p= 0.001). Nonetheless pulse pressure was higher in patients with significant RAS (68.5 mmHg) than in the remaining patients (50 mmHg) (p=0.001). Patients with significant RAS were also more frequently diabetic (73.5% to 26.7%, p=0.001), had dyslipidemia (86.8% to 50%, p= 0.001) and were being treated with statins (72.1% to 28.7%, p= 0.001). The presence of significant RAS was associated with a reduced eGFR (p= 0.001) (Table II) . Patients with significant RAS had more PAD (p=0.001) and chronic renal failure (p=0.001). The study also showed patients with significant RAS had more frequent CAD, especially two or three vessel disease. 82.3% of patients with significant RAS had at least one-vessel coronary involvement; 27.9% of them had two-vessel disease, 30.9% three-vessel disease and 4.4% LMCA disease. On the other hand 17.7% of patients with significant RAS had noncritical coronary stenosis (< 70% in at least one vessel) or normal coronary artery.
DIScuSSION
This study has shown that the prevalence of RAS is 8.9% in patients undergoing coronary angiography and who have cardiovascular risk factors. Impaired renal functions, diabetes mellitus, advanced age, dyslipidemia and increased pulse pressure are the risk factors for the RAS. Performing renal angiography after cardiac catheterization seems to be appropriate in patients with these risk factors. The prevalence of RAS has been identified in several studies with varying frequency (3.6-18%). These differences could be associated with the patient selection and diagnostic approach. Marc Antoni et al. (8) have found the RAS prevalence 5.4% in their study that had similar patient selection criteria to ours. They identified the risk factors for RAS as PAD, impaired renal function, advanced age, dyslipidemia, CAD (coronary artery disease) severity and wide pulse pressure. We also similarly identified impaired renal function, advanced age, dyslipidemia, and increased pulse pressure as absolute risk factors for RAS. Nevertheless, diabetes mellitus, which is a major risk factor for atherosclerotic vascular disease, can be accepted as a relative risk factor for RAS.
türk Nefroloji Diyaliz ve transplantasyon Dergisi
In another study, Buller et al. (7) performed renal angiography after cardiac catheterization in 851 patients who had at least one major risk factor such as severe hypertension, unexplained renal dysfunction, acute pulmonary edema due to hypertension and severe atherosclerosis. Renal artery atherosclerosis was found in 39% of the patients, but ≥ 50% stenosis was observed in 14.3%. In our study, the reason for the relatively low prevalence of RAS may be related to the selection of patients regardless of RAS risk factors.
In a study performed by Kobo et al. (13) , the significant RAS prevalence was found to be 9.1% in 450 patients who had risk factors such as PAD, resistant hypertension, renal failure and pulmonary edema. Although these results are compatible with ours, our prevalence of RAS could be higher than what we found if we had selected the patients using the criteria of the Kobo et al. study.
The different results of the prevalence of RAS varying from 3,6% to 18% may be explained by the selection of different criteria for the studies and the number of the patients.
Bazemore TC et al. investigated the relation of pulse and systolic and mean blood pressure with severe renal RAS (14) . The study demonstrated that severe RAS was associated with a lower diastolic BP and a higher pulse pressure (14) . This can be explained by the maintenance of kidney perfusion by higher pulse pressure. We showed that pulse pressure was higher in patients with significant RAS, and this was consistent with the mentioned study.
Although hypertension, antihypertensive therapy with multiple drugs, multiple CAD, PAD and the history of MI were not determined as a primary risk factors in our study, the patients who had the mentioned risk factors had statistically significantly higher rates of RAS. These patients should be carefully evaluated for RAS.
We also found that the prevalence of RAS is higher in patients who are using antihypertensive and antiatherosclerotic therapy with antiplatelet drugs, ACEI or ARB, beta blockers, CCB and statins. The patients who take such medications should be evaluated in terms of RAS.
Using anti-hypertensive and statin therapy provides important clues for the detection of RAS in patients with ischemic heart disease. According to the results of the study, ACE inhibitor or ARB, beta-blocker, CCB, and statin use was more common in patients with RAS. They seem to be predictors for the diagnosis of RAS but establishing a direct relationship does not seem appropriate.
Study Limitations
The limitations of our study are that DSA was not used for the screening of the renal arteries, the relatively lower number of patients, and including patients in the study regardless of the specific risk factors mentioned above.
cONcLuSION
Although the prevalence of RAS varies in different studies, we think that screening patients who have impaired renal functions, diabetes mellitus, advanced age, dyslipidemia and increased pulse pressure is useful for RAS detection. Further studies designed with a higher number of the patients who have specific risk factors for RAS are needed. 
